Lenalidomide is a cornerstone therapy for multiple myeloma (MM) and other hematologic malignancies, but conventional oral dosing is limited by high peak plasma concentrations, rapid clearance, and ...
Hematologic malignancies are a heterogeneous group of diseases with unique illness trajectories, treatment paradigms, and potential for curability, which affect patients’ palliative and end-of-life ...
The partnership will automate manufacturing of ProT-096, a personalized progenitor T-cell therapy for refractory leukemia and ...
Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results